HAEMATO Future Growth

Future criteria checks 2/6

HAEMATO is forecast to grow earnings and revenue by 8.3% and 5.7% per annum respectively.

Key information

8.3%

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth24.9%
Revenue growth rate5.7%
Future return on equityn/a
Analyst coverage

Low

Last updated12 Jun 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0VZ7 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202530311N/AN/A1
12/31/2024281109102
12/31/20232688342
6/30/2023261101011N/A
3/31/202325491416N/A
12/31/202224881920N/A
9/30/202225142122N/A
6/30/202225402424N/A
3/31/202227031919N/A
12/31/202128571414N/A
9/30/202128061212N/A
6/30/202127451010N/A
3/31/202125601212N/A
12/31/2020238-51415N/A
9/30/2020229-345N/A
6/30/2020220-2-6-5N/A
3/31/2020209-2-5-4N/A
12/31/2019198-1-4-3N/A
9/30/2019211-101N/A
6/30/2019224-145N/A
3/31/2019249323N/A
12/31/20182746-11N/A
9/30/20182848N/AN/AN/A
6/30/201829410-4-3N/A
3/31/20182928-7-6N/A
12/31/20172897-10-8N/A
9/30/20172818N/AN/AN/A
6/30/2017272978N/A
3/31/201727410N/A10N/A
12/31/201627611N/A13N/A
9/30/20162739N/AN/AN/A
6/30/20162717N/A4N/A
3/31/20162506N/A4N/A
12/31/20152306N/A3N/A
9/30/20152105N/AN/AN/A
6/30/20151905N/A2N/A
3/31/20151966N/A4N/A
12/31/20142037N/A7N/A
9/30/20142149N/A8N/A
6/30/201422410N/A9N/A
3/31/20141999N/A3N/A
12/31/20131748N/A-4N/A
9/30/20131267N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0VZ7's forecast earnings growth (8.3% per year) is above the savings rate (1.8%).

Earnings vs Market: 0VZ7's earnings (8.3% per year) are forecast to grow slower than the UK market (12.6% per year).

High Growth Earnings: 0VZ7's earnings are forecast to grow, but not significantly.

Revenue vs Market: 0VZ7's revenue (5.7% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: 0VZ7's revenue (5.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 0VZ7's Return on Equity is forecast to be high in 3 years time


Discover growth companies